Omega Therapeutics Debt to Equity

As of the most recent data, OMGA shows a debt-to-equity ratio of 11.1. That is above the Healthcare sector average of 0.27. Scroll down for historical charts and peer comparison views.

The Healthcare sector average debt-to-equity ratio is about 0.27. Omega Therapeutics is at 11.1, which is higher that average. That is roughly 4080.6% above the sector mean. Use the comparison chart on this page to see how OMGA stacks up against individual peers as well.

Investors watch OMGA's debt-to-equity ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Omega Therapeutics's latest reading is 11.1. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this debt-to-equity ratio page, Stockcircle has Omega Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect debt-to-equity ratio (currently 11.1) with ownership activity and broader fundamentals.

The Healthcare average debt-to-equity ratio is about 0.27, while OMGA is at 11.1. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.